Abstract : Cardiac resynchronization therapy CRT is a well-established, ef cient strategy for medically-refractory congestive heart failure HF with ventricular conduction disturbances. However, about 30 of patients who undergo CRT do not receive any bene t. Therefore, we investigated the usefulness of the QRS-left ventricle LV interval for predicting responders during CRT implantation. This study included 66 patients who underwent CRT implantation. The de nition of responder was a ≥ 15 reduction in LV end-systolic volume or ≥ 20 increase in LV ejection fraction. The QRS-LV interval was measured from the beginning of the body surface electrocardiogram QRS complex to the LV potential recorded by LV leads. We analyzed the correlations between the QRS-LV intervals and CRT responders, admission for HF and mortality. The patients were 67 12 years old, and their mean LV ejection fraction was 26.3 8.3 . During follow-up 27.2 19.9 months , 27 patients were admitted for HF 40.1 , and 17 died 25.7 ; the median QRS-LV interval was 103 33 msec. Patients were divided into 2 groups: wide QRS-LV 103 msec , and narrow QRS-LV 103 msec . The wide QRS-LV group had a lower mortality rate than the narrow QRS-LV group 77 vs. 53 , P 0.05 . In patients with dilated cardiomyopathy, the QRS-LV interval was signi cantly wider in responders, compared to non-responders 112 9.2 vs. 80.0 10 msec, P 0.05 . The QRS-LV interval did not correlate with CRT responders or admission for HF. The mortality rate was lower in patients with wide QRS-LV intervals, compared to narrow QRS-LV intervals. Furthermore, a wide QRS-LV interval might be a predictor for CRT responders in patients with dilated cardiomyopathy.
Introduction
Cardiac resynchronization therapy CRT is a well-established and efficient strategy for
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medically-refractory congestive heart failure HF in patients with wide QRS duration, and this therapy is associated with a reduction of symptoms, improvement of ejection fraction EF , and decrease in hospitalization and mortality [1] [2] [3] [4] . In particular, in patients with left bundle branch block CLBBB and wide QRS duration, CRT tends to be effective for left ventricular LV reverse remodeling 5 . This suggests that a LV electrical delay might be a factor in predicting CRT responders. However, about 30 of patients who undergo CRT do not receive any bene t from CRT 6 7 and responders cannot be predicted by QRS waveform and QRS duration alone. Furthermore, inadequate selection criteria for identifying potential responders, based on QRS duration, result in a high rate of non-responders. Therefore, this study investigated the relationship between such electrical delay at the LV leads and CRT responders.
Material and methods

Patients and study protocol
This study included 66 patients who underwent CRT implantation from June 2008 to August 2013. The mean follow-up period was 27.2 19.9 months. Patients with advanced HF were New York Heart Association functional class , or , and had decreased LVEF 40 or less and wide QRS complexes 120 msec . Patients with the following criteria were excluded : 1 patients who did not visit after hospital discharge ; 2 history of cardiac surgery within 1 month after implantation; 3 acute myocardial infarction, unstable angina or stroke within 1 month ; 4 acute HF; and 5 permanent atrial brillation.
Echocardiographic evaluation
Patients underwent echocardiography in the left lateral decubitus position. LVEF and LV end-systolic volume LVESV were assessed by the biplane Simpson s equation using the apical 4-chamber and 2-chamber views, before and 6 months after CRT implantation. Patients were classi ed as responders if their LVEF increased by at least 20 , and/or the LVESV decreased by at least 15 with respect to baseline variations were considered as relative values . Patients were de ned as non-responders if they did not reach both of the above pre-speci ed echocardiographic changes 8 .
Measurements
We measured the QRS-LV interval during sinus rhythm. The QRS-LV interval was de ned as the distance measured from the beginning of the QRS complex, recorded by the body surface electrocardiogram ECG , to the rst large positive or negative peak of the LV potential, recorded by the LV leads during CRT implantation Fig. 1 . We calculated the median QRS-LV interval and divided the patients into 2 groups, based on this measurement: wide QRS-LV group QRS-LV interval 103 msec , and narrow QRS-LV group QRS-LV interval 103 msec . Furthermore, we evaluated the implantable cardioverter-de brillator therapy after implantation using the device reports. The assessment of shock therapy and anti-tachycardia pacing therapy was also evaluated using the device reports. Two electrophysiologists measured the ECG and echocardiographic data.
CRT-de brillator CRT-D implantation and de nitions
The decision to implant CRT-Ds was based on the American College of Cardiology / American Heart Association / Heart Rhythm Society guidelines for device-based therapy of cardiac rhythm abnormalities and the guidelines for non-pharmacotherapy of cardiac arrhythmias published by the Japanese Circulation Society 9 10 . LV pacing was performed with a lead into a branch of the coronary sinus n 66 . The LV lead was implanted transvenously via the coronary sinus tributaries and placed preferably to stimulate the lateral or postero-lateral LV wall.
Statistical analysis
Data are presented as mean standard deviation. Differences in baseline characteristics between the 2 groups were analyzed using unpaired t tests. Paired t tests were used to compare continuous data within the subgroups during follow-up. P values 0.05 were considered statistically signi cant. The authors had full access to and take full responsibility for the integrity of the data.
Results
Patient characteristics
We investigated and analyzed a total of 66 patients which received CRT. Baseline characteristics are summarized in Table 1 . There were 56 men and 10 women, and their mean age was 67 12 years. The mean LVEF before CRT was 26.3 8.3 . Twenty patients 30 had dilated cardiomyopathy DCM . Medical therapies included beta-blockers 70 , diuretics 89 , angiotensin receptor blockers / angiotensin converting-enzyme inhibitors 67 , and amio- darone 21 . QRS morphology and ECG ndings are summarized in Table 2 . Twenty-six patients had CLBBB. The mean QRS duration was 148 26 msec, the mean QRS-LV interval was 103 33 msec, and the median QRS-LV interval was 103 msec. Values are n , unless otherwise indicated. SD, standard deviation ; NYHA, New York Heart Association ; LVEF, left ventricular ejection fraction ; ACE I, angiotensinconverting enzyme inhibitor; ARB, angiotensin II receptor blocker.
Comparison of ECG and clinical characteristics between the 2 groups
The median QRS-LV interval was 103 msec, so we divided patients into 2 groups: wide QRS-LV QRS-LV 103 msec and narrow QRS-LV QRS-LV 103 msec . Table 3 shows the comparison of ECG and clinical characteristics between the wide and narrow QRS-LV groups. Thirty-two patients did not have follow-up echocardiography at 6 months due to death or dropout. This included 18 patients from the narrow QRS-LV group and 14 patients from the wide QRS-LV group. Ten of these 32 patients died 9 from the narrow QRS-LV group and one from the wide QRS-LV group and the remaining 22 patients were dropouts. Therefore the nal analysis included 15 patients in the wide QRS-LV group and 19 in the narrow QRS-LV group. CLBBB morphology was more frequent in the wide QRS-LV group, compared to the narrow QRS-LV group 63 vs. 34 , respectively; P 0.08 . There were no signi cant differences for ventricular tachycardia events, or CRT responders or non-responders between the 2 groups. Fig. 2 shows the Kaplan-Meier estimates of the percentage of patients remaining free from readmission for HF and all-cause mortality. The X-axis shows the duration of follow-up days after CRT. The readmission free rate for HF was 60 in the wide QRS-LV group, and 24 in the narrow QRS-LV group during the follow-up period. Freedom from all-cause mortality was 77 in the wide QRS-LV group, and 53 in the narrow QRS-LV group log rank test, P 0.04 . Values are n , unless otherwise indicated. Thirty-two patients were not included in the nal analysis due to death or dropout 18 patients from the narrow QRS-LV group, and 14 from the wide QRS-LV group . Of these 32 patients, 10 died, including 9 from the narrow QRS-LV group heart failure 7 , sudden death 1 , ventricular tachycardia 1 , and 1 from the wide QRS-LV group cancer ; 22 patients dropped out of the study. LV, left ventricular ; CLBBB, complete left bundle branch block ; CRBBB, complete right bundle branch block ; RV, right ventricular; SD, standard deviation. Fig. 3 shows the relationship between QRS-LV interval and CRT responders for all patients and patients with DCM. In patients with DCM, CRT responders had a signi cantly wider QRS-LV interval, compared to the non-responders 117 28 msec vs. 83 35 msec, respectively ; P 0.01 . In the DCM patients, 9 had CLBBB 45 , two had CRBBB 10 , 8 had intraventricular conduction delay 40 , and 1 had RV pacing 5 .
Comparison of mortality and responders between the 2 groups
Discussion
Main ndings
The most important nding of this study is that freedom from all-cause mortality was higher in patients with a wide QRS-LV interval QRS-LV interval 103 msec , compared to a narrow QRS-LV interval. In patients with DCM, CRT responders had a signi cantly wider QRS-LV Fig. 2 . Kaplan-Meier estimates of the percentage of patients remaining free from readmission for heart failure A and all-cause mortality B for the wide and narrow QRS-LV interval groups. The X-axis shows follow-up in days, after cardiac resynchronization therapy-defibrillator implantation. interval than non-responders. Furthermore, CLBBB morphology was more frequent in the wide QRS-LV group, compared to the narrow QRS-LV group.
CRT responders and non-responders
CRT is a rapidly evolving therapeutic modality for patients with severe HF and intraventricular conduction delays. Furthermore, Gold et al 11 reported that ventricular tachycardia was lower in patients whose LVESV decreased by at least 15 after CRT, compared to those whose LVESV did not decrease by 15 . These results suggest that effectiveness of CRT could be assessed by LVEF improvement and LVESV reduction. However, when de ning CRT responders as those with an increased LVEF of at least 20 , and / or a decrease in LVESV of at least 15 , with respect to baseline, about 30 of patients fail to show improvement in clinical symptoms 12 13 , and 40 -50 of patients have no improvement in LV function on echocardiography 14 15 , Moreover, sophisticated echocardiographic studies have failed to predict appropriate candidates for CRT 16 .
Bonakdar et al 17 described that not only baseline QRS duration but also QRS narrowing immediately after CRT can predict long-term response. In addition, acute hemodynamic improvement post-implant might predict long-term responders 17 .
In our study, patients in the wide QRS-LV group had wider QRS durations, compared to the narrow QRS-LV group. However, the QRS-LV interval on local ventricular ECG was not clearly associated with responders.
Association of QRS-LV interval and CRT responders
One important bene t of CRT is to achieve more synchronicity in the electrically-delayed LV area 18 . CLBBB and QRS duration have been used to determine the adaption of CRT, however, some patients with prolonged QRS duration receive few bene ts from CRT. Furthermore, optimal LV lead pacing sites are controversial. Butter et al 19 reported that the lateral position was associated with a better outcome. The MADIT-CRT trial suggested that apical leads were associated with worse outcomes, rather than non-lateral leads, however, other studies have shown that apical leads can be optimal pacing sites [20] [21] [22] . Anatomical position, CLBBB and QRS duration cannot determine an adequate LV lead position. In our study, DCM patients had a higher CRT response rate than all other patients, regardless of CLBBB. QRS duration shows total ventricular excitement, whereas the electrical potential of the LV leads indicate delay potential in the local LV area. Therefore, the QRS-LV interval might be useful for nding the delayed LV area, allowing us to determine the adequate LV pacing point. Furthermore, patients who were CRT responders were likely to have LV reverse remodeling. The study by Gold et al 23 supports this suggestion. To ensure a good response to CRT, it is desirable to have an indicator that re ects the degree of delayed LV activation at the pacing site. The QRS-LV interval is such an index. The QRS onset is the earliest ventricular activation which usually starts in the septum. Thus the QRS-LV interval re ects the time that it takes for the ventricular depolarization wave front to reach the LV electrode site, and thus synchronization would occur with pacing at that site. It is intriguing to speculate that this could be utilized during the implant procedure to determine an area of late activation by repositioning the LV electrode and examining the QRS-LV value at different locations.
Association of QRS-LV interval and mortality
Previous studies reported that patients with CLBBB and a wide QRS duration 150 msec or greater had lower risks of mortality and all-cause mortality, and cardiovascular and HF readmission, than those with QRS durations of 120-149 msec. CLBBB plus wide QRS duration was a predictor of a better CRT outcome 5 17 . The relationship between the degree of electrical LV activation delay and QRS was strong 13 , suggesting that QRS-LV could be an electrical LV delay indicator, and that the QRS-LV interval may re ect the effectiveness of CRT. Therefore, in our study, the wide QRS-LV group had a lower mortality than the narrow QRS-LV group.
Study limitations
The study has several limitations. First, the number of patients was relatively small. However, we believe that this study is an adequate evaluation as there was a signi cant difference between the wide and narrow QRS-LV interval groups. Second, this study was a retrospective observational analysis of prospectively assessed data evaluating QRS-LV interval. Further prospective studies will be required to ascertain the relationship between the QRS-LV interval and CRT responders.
Conclusions
The wide QRS-LV group 103 msec had a lower mortality rate than the narrow QRS-LV group. In patients with DCM, the QRS-LV interval was significantly wider in the CRT responder group, compared to the non-responder group. Therefore, a wide QRS-LV interval might be associated with a favorable outcome.
